AOD9604 has been characterised across pre-clinical, safety pharmacology, and early-phase clinical research since the late 1990s, with peer-reviewed publications spanning lipid metabolism, adipose biology, joint repair, and bioavailability
Moreover, dysregulated lipid metabolism networks such as ACSL/SCD also drive EMT and migratory properties, and their pharmacologic inhibition selectively impairs CRC cell viability, further broadening the landscape of metabolic vulnerabilities in metastatic CRC [96]
AOD 9604 safety data Six randomized, double-blind, placebo-controlled trials enrolling 925 adult subjects established AOD 9604 safety
However, the Oxford researchers admitted the science is solid on glutathione and NACs ability to combat oxidative stress and inflammation associated with active viral infections, including influenza A